LakeShore Biopharma Announces Appointment of Independent Financial Advisor and Legal Counsel to the Special Committee

Core Viewpoint - LakeShore Biopharma has formed a Special Committee to evaluate a revised preliminary non-binding acquisition proposal and has engaged financial and legal advisors for this process [1][2]. Company Overview - LakeShore Biopharma, formerly known as YS Biopharma, is a global biopharmaceutical company focused on developing vaccines and therapeutic biologics for infectious diseases and cancer [3]. - The company utilizes a proprietary PIKA immunomodulating technology platform and targets diseases such as Rabies, Hepatitis B, and Influenza [3]. - LakeShore Biopharma operates in China, Singapore, and the Philippines, led by a management team with extensive local and global biopharmaceutical experience [3].